This case report describes a vasoproliferative tumor in a 16-year-old male patient with Coats’ disease, treated with laser photocoagulation, cryoablation, and anti-vascular endothelial growth factor injections therapies, that developed an epiretinal membrane as a complication. The surgical treatment in association with the retinal laser treatment greatly improved visual acuity. At 8 months follow-up from surgery, visual acuity had significantly improved, and macular anatomy recovered. Vasoproliferative tumors may occur in patients with Coats’ disease, and in such a clinical scenario, a multiple therapeutical approach should be considered, in order to reach the best anatomical and functional outcome for the patient.
Management of Vasoproliferative Tumor in a Patient With Coats’ Disease: Multiple Therapeutic Approach in Current Era / Bottazzi, L.; L'Abbate, G.; Fossataro, C.; Savastano, M. C.; Sacconi, R.; Rizzo, S.; Bandello, F.; Querques, G.. - In: OPHTHALMIC SURGERY, LASERS & IMAGING RETINA. - ISSN 2325-8160. - 56:8(2025), pp. 502-505. [10.3928/23258160-20250522-01]
Management of Vasoproliferative Tumor in a Patient With Coats’ Disease: Multiple Therapeutic Approach in Current Era
Querques G.
2025
Abstract
This case report describes a vasoproliferative tumor in a 16-year-old male patient with Coats’ disease, treated with laser photocoagulation, cryoablation, and anti-vascular endothelial growth factor injections therapies, that developed an epiretinal membrane as a complication. The surgical treatment in association with the retinal laser treatment greatly improved visual acuity. At 8 months follow-up from surgery, visual acuity had significantly improved, and macular anatomy recovered. Vasoproliferative tumors may occur in patients with Coats’ disease, and in such a clinical scenario, a multiple therapeutical approach should be considered, in order to reach the best anatomical and functional outcome for the patient.Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




